Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

The coming of age of cyclic peptide drugs: an update on discovery technologies

Cyclic peptide therapeutics: past, present and future

Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery

Cyclic peptides: a powerful instrument for advancing biomedical nanotechnologies and drug development

Cyclic Peptides in Pipeline: What Future for These Great Molecules?

Display Technologies for Expanding the Pharmaceutical Applications of Cyclotides

Cyclic peptide drugs approved in the last two decades (2001–2021)

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides

Biosynthetic Strategies for Macrocyclic Peptides

Peptide therapeutics: Targeting the undruggable space

The latest trends in peptide drug discovery and future challenges

Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective

Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries

Recent Advances in Non‐Standard Macrocyclic Peptide Ligand Discovery using mRNA Display

Overcoming the shortcomings of peptide-based therapeutics

Strategies for the Construction of Multicyclic Phage Display Libraries

A novel cyclic peptide library immobilized on gel‐type beads focusing on rapid construction and characterization for comprehensive drug discovery

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications